|
FR2646776B1
(fr)
*
|
1989-05-12 |
1994-06-03 |
Pasteur Institut |
Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
|
|
US6620414B2
(en)
*
|
1992-03-27 |
2003-09-16 |
Smithkline Beecham Biologicals (S.A.) |
Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US20010053365A1
(en)
*
|
1995-04-25 |
2001-12-20 |
Smithkline Beecham Biologicals S.A. |
Vaccines
|
|
UA56132C2
(uk)
†
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
AU1145699A
(en)
*
|
1997-09-05 |
1999-03-22 |
Smithkline Beecham Biologicals (Sa) |
Oil in water emulsions containing saponins
|
|
US7087236B1
(en)
*
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
EP1156781B1
(en)
|
1999-02-26 |
2005-06-08 |
Chiron Corporation |
Microemulsions with adsorbed macromolecules and microparticles
|
|
PT1187629E
(pt)
*
|
1999-04-19 |
2005-02-28 |
Glaxosmithkline Biolog Sa |
Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
|
|
US6558670B1
(en)
|
1999-04-19 |
2003-05-06 |
Smithkline Beechman Biologicals S.A. |
Vaccine adjuvants
|
|
GB9908885D0
(en)
*
|
1999-04-19 |
1999-06-16 |
Smithkline Beecham Biolog |
Vccine
|
|
NZ515322A
(en)
|
1999-05-13 |
2004-03-26 |
Wyeth Corp |
Adjuvant combination formulations
|
|
GB9923176D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
CA2388337C
(en)
|
1999-10-22 |
2013-01-08 |
Aventis Pasteur Limited |
Method of inducing and/or enhancing an immune response to tumor antigens
|
|
NZ520976A
(en)
*
|
1999-11-19 |
2005-01-28 |
Csl Ltd |
Vaccine compositions
|
|
DK1282702T3
(da)
|
2000-05-10 |
2007-04-02 |
Sanofi Pasteur Ltd |
Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
|
|
SI2266603T1
(sl)
|
2000-10-18 |
2012-12-31 |
Glaxosmithkline Biologicals S.A. |
Tumorska cepiva
|
|
US20030138434A1
(en)
*
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
|
US7361352B2
(en)
|
2001-08-15 |
2008-04-22 |
Acambis, Inc. |
Influenza immunogen and vaccine
|
|
US7351413B2
(en)
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
US6861410B1
(en)
*
|
2002-03-21 |
2005-03-01 |
Chiron Corporation |
Immunological adjuvant compositions
|
|
JP4726485B2
(ja)
*
|
2002-08-02 |
2011-07-20 |
大日本住友製薬株式会社 |
細菌細胞壁骨格成分製剤
|
|
AU2003285932A1
(en)
|
2002-10-23 |
2004-05-13 |
Glaxosmithkline Biologicals S.A. |
Methods for vaccinating against malaria
|
|
EP2263687B1
(en)
*
|
2002-12-27 |
2015-03-25 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions containing phospholipid
|
|
MXPA05008051A
(es)
*
|
2003-01-29 |
2005-09-21 |
Pfizer Prod Inc |
Vacunas caninas contra bordetella bronchiseptica.
|
|
AU2004226591B2
(en)
*
|
2003-04-04 |
2009-06-04 |
Zoetis Services Llc |
Microfluidized oil-in-water emulsions and vaccine compositions
|
|
US7972645B2
(en)
*
|
2003-12-01 |
2011-07-05 |
Academia Sinica |
Dioscorea extracts for enhancing immune system
|
|
KR20110132416A
(ko)
*
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
JP5041279B2
(ja)
*
|
2004-04-22 |
2012-10-03 |
株式会社 Ｍｂｒ |
細菌細胞壁骨格成分を含有する製剤
|
|
GB0417494D0
(en)
|
2004-08-05 |
2004-09-08 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
ES2357968T3
(es)
*
|
2005-02-16 |
2011-05-04 |
Cornell Research Foundation, Inc. |
Composiciones para desencadenar una respuesta inmunitaria contra mycobacterium avium subespecie paratuberculosis.
|
|
NZ560930A
(en)
*
|
2005-02-16 |
2011-06-30 |
Novartis Vaccines & Diagnostic |
Hepatitis B virus vaccine comprising a hepatitis B virus surface antigen, aluminium phosphate, 3-O-deacylated monophosphoryl lipid A and a triethylammonium ion
|
|
GB0503337D0
(en)
|
2005-02-17 |
2005-03-23 |
Glaxosmithkline Biolog Sa |
Compositions
|
|
GB0504436D0
(en)
|
2005-03-03 |
2005-04-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
AR054020A1
(es)
*
|
2005-03-23 |
2007-05-30 |
Glaxosmithkline Biolog Sa |
Nuevo uso
|
|
EP1910410B1
(en)
*
|
2005-07-01 |
2011-10-26 |
Forsyth Dental Infirmary for Children |
Tuberculosis antigen detection assays and vaccines
|
|
DK1909830T3
(da)
*
|
2005-08-02 |
2011-12-19 |
Novartis Vaccines & Diagnostic |
Formindskelse af interferens mellem olieholdige adjuvanser og antigener indeholdende overfladeaktivt middel
|
|
US11707520B2
(en)
|
2005-11-03 |
2023-07-25 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
CA2628152C
(en)
|
2005-11-04 |
2016-02-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
JP2009514844A
(ja)
*
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
|
|
GB0522765D0
(en)
|
2005-11-08 |
2005-12-14 |
Chiron Srl |
Combination vaccine manufacture
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP2476433A1
(en)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
|
US9839685B2
(en)
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
|
MX2009000660A
(es)
|
2006-07-17 |
2009-04-08 |
Glaxosmithkline Biolog Sa |
Vacuna de influenza.
|
|
US20080014217A1
(en)
*
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
PL2068918T5
(pl)
|
2006-09-26 |
2024-12-02 |
Access To Advanced Health Institute |
Kompozycja szczepionki zawierająca syntetyczny adiuwant
|
|
EP2433648A3
(en)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
EA015817B1
(ru)
*
|
2006-10-12 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
|
|
PL2137210T3
(pl)
|
2007-03-02 |
2017-06-30 |
Glaxosmithkline Biologicals Sa |
Nowy sposób i kompozycje
|
|
CA2679720A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Merck & Co., Inc. |
Papillomavirus vaccine compositions
|
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
EA017887B1
(ru)
|
2007-08-02 |
2013-03-29 |
Байондвакс Фармасьютикалз Лтд. |
Полимерные мультиэпитопные вакцины против гриппа
|
|
KR20100068390A
(ko)
|
2007-08-13 |
2010-06-23 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
CN106310293A
(zh)
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
ES2553113T3
(es)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
WO2009143524A2
(en)
|
2008-05-23 |
2009-11-26 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
WO2009146523A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
CN102223876A
(zh)
|
2008-09-26 |
2011-10-19 |
纳米生物公司 |
纳米乳剂治疗性组合物及其使用方法
|
|
EP3173097A3
(en)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
PE20110992A1
(es)
*
|
2009-02-17 |
2012-02-12 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica que comprende un antigeno del virus del dengue
|
|
WO2010132833A1
(en)
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
CA2765511C
(en)
|
2009-06-16 |
2015-05-12 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
EP2353609A1
(en)
|
2010-02-04 |
2011-08-10 |
Sanofi Pasteur |
Immunization compositions and methods
|
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
|
EP2575878B1
(en)
*
|
2010-05-28 |
2018-06-13 |
Zoetis Belgium S.A. |
Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
|
|
GB201009671D0
(en)
*
|
2010-06-10 |
2010-07-21 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
|
BR112013004582A2
(pt)
|
2010-09-27 |
2016-09-06 |
Crucell Holland Bv |
método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
|
JP6205360B2
(ja)
|
2011-08-22 |
2017-09-27 |
ナノバイオ コーポレーション |
単純ヘルペスウイルスのナノエマルジョンワクチン
|
|
CN104093421A
(zh)
|
2011-09-09 |
2014-10-08 |
纳诺碧欧公司 |
纳米乳液呼吸道合胞病毒(rsv)亚单位疫苗
|
|
PL2758432T3
(pl)
|
2011-09-16 |
2019-08-30 |
Ucb Biopharma Sprl |
Przeciwciała neutralizujące przeciw głównym egzotoksynom tcda i tcdb z clostridium difficile
|
|
DK2750683T4
(da)
|
2011-10-03 |
2021-04-12 |
Croda Int Plc |
Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærer for amfipatiske eller hydrofobe molekyler inden for medicin, herunder cancerbehandling, og i fødevarerelaterede forbindelser
|
|
CN113876945A
(zh)
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
US20130122038A1
(en)
|
2011-11-14 |
2013-05-16 |
The United States Of America As Represented By The Secretary Of The Department |
Heterologous prime-boost immunization using measles virus-based vaccines
|
|
WO2013083753A2
(en)
|
2011-12-07 |
2013-06-13 |
Institut Pasteur |
Identification of a swine parecho-like virus and applications
|
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
|
EP3492095A1
(en)
|
2012-04-01 |
2019-06-05 |
Technion Research & Development Foundation Limited |
Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
|
|
HRP20181102T1
(hr)
|
2012-05-16 |
2018-09-07 |
Immune Design Corp |
Cjepiva za hsv-2
|
|
SG10201912291YA
(en)
|
2012-07-24 |
2020-02-27 |
Sanofi Pasteur |
Vaccine compositions
|
|
AU2013295016A1
(en)
|
2012-07-24 |
2015-01-29 |
Sanofi Pasteur |
Vaccine compositions for prevention against dengue virus infection
|
|
US9982034B2
(en)
|
2012-10-24 |
2018-05-29 |
Platelet Targeted Therapeutics, Llc |
Platelet targeted treatment
|
|
BR112015012515B1
(pt)
|
2012-11-30 |
2023-04-11 |
Sanofi Pasteur |
Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola
|
|
MX370573B
(es)
|
2013-04-18 |
2019-12-17 |
Immune Design Corp |
Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
KR101977449B1
(ko)
|
2013-11-01 |
2019-05-10 |
유니버시티에트 이 오슬로 |
알부민 변이체 및 이의 용도
|
|
US10357554B2
(en)
|
2013-11-11 |
2019-07-23 |
The United States Of America, As Represented By The Secretary Of The Army |
AMA-1 epitopes, antibodies, compositions, and methods of making and using the same
|
|
WO2015071769A2
(en)
|
2013-11-13 |
2015-05-21 |
University Of Oslo |
Outer membrane vesicles and uses thereof
|
|
DK3069138T3
(en)
|
2013-11-15 |
2019-04-08 |
Univ Oslo Hf |
CTL PEPTID EPITOPES AND ANTIGEN-SPECIFIC T-CELLS, METHODS OF RECOGNITION THEREOF, AND APPLICATIONS THEREOF
|
|
AU2014352986A1
(en)
|
2013-11-20 |
2016-06-16 |
Alk-Abello A/S |
Pan pollen immunogens and methods and uses thereof for immune response modulation
|
|
WO2015077442A2
(en)
|
2013-11-20 |
2015-05-28 |
La Jolla Institute For Allergy And Immunology |
Grass pollen immunogens and methods and uses for immune response modulation
|
|
WO2015092710A1
(en)
|
2013-12-19 |
2015-06-25 |
Glaxosmithkline Biologicals, S.A. |
Contralateral co-administration of vaccines
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
WO2015112485A1
(en)
|
2014-01-21 |
2015-07-30 |
Immune Design Corp. |
Compositions for use in the treatment of allergic conditions
|
|
WO2015131053A1
(en)
|
2014-02-28 |
2015-09-03 |
Alk-Abelló A/S |
Polypeptides derived from phl p and methods and uses thereof for immune response modulation
|
|
KR101696514B1
(ko)
*
|
2014-08-18 |
2017-01-24 |
서울대학교산학협력단 |
신규한 온도 민감성 마이코박테리아 균주 및 이를 포함하는 마이코박테리아 감염증에 대한 백신 조성물
|
|
EP4112076A1
(en)
|
2014-10-10 |
2023-01-04 |
The Regents of The University of Michigan |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
|
AU2015252119A1
(en)
|
2014-11-07 |
2016-05-26 |
Takeda Vaccines, Inc. |
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
|
|
AR102547A1
(es)
|
2014-11-07 |
2017-03-08 |
Takeda Vaccines Inc |
Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
|
|
CN107530416A
(zh)
|
2015-03-05 |
2018-01-02 |
西北大学 |
非神经侵染的病毒及其用途
|
|
GB201518668D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Immunogenic Comosition
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
WO2017158421A1
(en)
|
2016-03-14 |
2017-09-21 |
University Of Oslo |
Anti-viral engineered immunoglobulins
|
|
CA3011887C
(en)
|
2016-03-14 |
2024-10-29 |
Universitetet I Oslo |
Genetically transformed immunoglobulins with altered FCRN binding
|
|
US11173207B2
(en)
|
2016-05-19 |
2021-11-16 |
The Regents Of The University Of Michigan |
Adjuvant compositions
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
US11780924B2
(en)
|
2016-06-21 |
2023-10-10 |
University Of Oslo |
HLA binding vaccine moieties and uses thereof
|
|
EP3504230A1
(en)
|
2016-08-23 |
2019-07-03 |
GlaxoSmithKline Biologicals SA |
Fusion peptides with antigens linked to short fragments of invariant chain (cd74)
|
|
GB201614799D0
(en)
|
2016-09-01 |
2016-10-19 |
Glaxosmithkline Biologicals Sa |
Compositions
|
|
WO2018060288A1
(en)
|
2016-09-29 |
2018-04-05 |
Glaxosmithkline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
AU2018283973B2
(en)
|
2017-06-11 |
2025-04-24 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
|
MX2019015076A
(es)
|
2017-06-15 |
2020-08-03 |
Infectious Disease Res Inst |
Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos.
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
EP3678698A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|
|
EP3678699A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|
|
KR20200117981A
(ko)
|
2017-11-03 |
2020-10-14 |
다케다 백신즈 인코포레이티드 |
지카 백신 및 면역원성 조성물, 그리고 이를 이용하는 방법들
|
|
GB201721068D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B immunisation regimen and compositions
|
|
GB201721069D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B Immunisation regimen and compositions
|
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
EP3807298A1
(en)
|
2018-06-12 |
2021-04-21 |
GlaxoSmithKline Biologicals S.A. |
Adenovirus polynucleotides and polypeptides
|
|
EP3833382A1
(en)
|
2018-08-07 |
2021-06-16 |
GlaxoSmithKline Biologicals S.A. |
Processes and vaccines
|
|
EP3897846A1
(en)
|
2018-12-21 |
2021-10-27 |
GlaxoSmithKline Biologicals SA |
Methods of inducing an immune response
|
|
CA3132601A1
(en)
|
2019-03-05 |
2020-09-10 |
Glaxosmithkline Biologicals Sa |
Hepatitis b immunisation regimen and compositions
|
|
CA3141577A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
EP3770269A1
(en)
|
2019-07-23 |
2021-01-27 |
GlaxoSmithKline Biologicals S.A. |
Quantification of bioconjugate glycosylation
|
|
FI20215508A1
(en)
|
2020-04-09 |
2021-10-10 |
Niemelae Erik Johan |
Mimetic nanoparticles to prevent the spread of new coronaviruses and reduce the rate of infection
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
CA3266697A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
COMPOSITION OF AN IMMUNOGENEOUS VACCINE CONTAINING A SAPONIN
|
|
WO2024133160A1
(en)
|
2022-12-19 |
2024-06-27 |
Glaxosmithkline Biologicals Sa |
Hepatitis b compositions
|
|
KR20260015203A
(ko)
|
2023-05-19 |
2026-02-02 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
호흡기 세포융합 바이러스 및 스트렙토코쿠스 뉴모니아에 감염에 대한 면역 반응을 유발하는 방법
|